Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Q2 2026 Earnings Call Transcript
Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RICFY) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Eugenia Litz - VP & Head of Investor Relations Robert Koremans - CEO & Director Luigi Felice Corte - Group CFO & Executive Director Scott Pescatore - Executive Vice President of Rare Diseases Business Unit Milan Zdravkovic - Executive VP of Research & Development and Chief Medical Officer Conference Call Participants Shan Hama - Jefferies LLC, Research Division Sophia Graeff Buhl Nielsen - JPMorgan Chase & Co, Research Division Isacco Brambilla - Mediobanca - Banca di credito finanziario S.p.A.